Home » Stocks » SLP

Simulations Plus, Inc. (SLP)

Stock Price: $66.46 USD 4.21 (6.76%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
Market Cap 1.24B
Revenue (ttm) 42.89M
Net Income (ttm) 9.75M
Shares Out 19.93M
EPS (ttm) 0.51
PE Ratio 130.57
Forward PE 119.05
Dividend $0.24
Dividend Yield 0.36%
Trading Day March 5
Last Price $66.46
Previous Close $62.25
Change ($) 4.21
Change (%) 6.76%
Day's Open 62.97
Day's Range 61.57 - 67.00
Day's Volume 404,284
52-Week Range 25.90 - 90.92

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant.

The Motley Fool - 2 weeks ago

What's better than rapid growth and a dividend payment?

Other stocks mentioned: ABBV, PINC
Business Wire - 3 weeks ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET.

Business Wire - 3 weeks ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the release of GastroPlus 9.8.1 with key enhancements to improve efficiency and inform regulatory decision making.

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced an agreement to distribute Lixoft's MonolixSuite in China with Mosim, one of China's leading clinical CROs.

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it is partnering with the Institute of Pharmaceutical Sciences (ICF) in Brazil, to expand into South America.

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has awarded a grant to Uganda's Makerere University funding upgraded infrastructure to facilitate research.

Zacks Investment Research - 1 month ago

Simulations Plus (SLP) fiscal first-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.

The Motley Fool - 1 month ago

The company continues to anticipate swift, double-digit revenue growth over the next several quarters.

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 12, 2021) -  Levi & Korsinsky announces it has commenced an investigation of Simulations Plus, Inc. (NASDAQ: SLP) concerning possible breaches of ...

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that CEO Shawn O'Connor will present at the 23rd Annual Needham Virtual Growth Conference on January 14, 2021, at 2pm ET.

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration with a large pharmaceutical partner to enhance PBPK/PD models for pulmonary therapeutics.

Seeking Alpha - 1 month ago

Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 1 month ago

Simulations Plus (SLP) delivered earnings and revenue surprises of 9.09% and 1.35%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 month ago

Shares of Simulations Plus (NASDAQ:SLP) were flat after the company reported Q1 results. Quarterly Results Earnings per share increased 9.09% year over year to $0.12, which beat the estimate o...

Business Wire - 1 month ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported record 1st quarter results for FY2021. Net revenues of $10.7 million increased 14%; net income was up 21% over 1QFY20.

Benzinga - 1 month ago

Simulations Plus (NASDAQ:SLP) releases its next round of earnings this Monday, January 11. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.

Zacks Investment Research - 1 month ago

Simulations Plus (SLP) fiscal first-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech i...

Business Wire - 2 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration to enhance its GastroPlus ACAT model with novel mechanisms for oral peptide formulations.

Business Wire - 2 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report its first quarter fiscal year 2021 results on Monday, Jan. 11, 2021, with a webcast at 4:15 pm ET

Zacks Investment Research - 2 months ago

We discuss three software stocks -- COUP, NUAN and SLP -- which might not sustain market beating run in 2021, owing to persistent macroeconomic weakness across SMBs induced by coronavirus outb...

Other stocks mentioned: COUP, NUAN
Business Wire - 2 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has published its inaugural Environmental, Social and Governance (ESG) report on its website's Investors page

Business Wire - 3 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the appointment of Will Frederick as CFO, succeeding John Kneisel who is retiring after 7 years with the Company.

Zacks Investment Research - 3 months ago

Simulations Plus (SLP) fiscal fourth-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.

Seeking Alpha - 3 months ago

Simulations Plus' (SLP) CEO Shawn O'Connor on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Simulations Plus (SLP) delivered earnings and revenue surprises of 20.00% and 0.85%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 3 months ago

Shares of Simulations Plus (NASDAQ:SLP) fell 2.16% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year t...

Business Wire - 3 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported results for the 4th quarter and fiscal year 2020. Full FY20 revenues increased 22.4%; 4QFY20 revenues increased 18.9%.

Business Wire - 3 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report its 4th quarter and fiscal year 2020 results on Mon., Nov. 16, 2020, with a webcast at 4:15 pm ET

Business Wire - 4 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that CEO Shawn O'Connor will be participating in the Credit Suisse Virtual Healthcare Conference on Nov. 10, 2020.

Zacks Investment Research - 4 months ago

Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 4 months ago

ORCL vs. SLP: Which Stock Is the Better Value Option?

Other stocks mentioned: ORCL
Business Wire - 4 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the release of GastroPlus 9.8 with key improvements to non-oral delivery models, virtual bioequivalence, and DDIs.

Business Wire - 4 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that its Board of Directors has declared a cash dividend of $0.06 per share to be distributed on Nov. 2, 2020.

InvestorPlace - 4 months ago

There’s a difference between high-priced and expensive, and some of the best growth stocks to buy under $1,000 come with big price tags. The post The 7 Best Growth Stocks To Buy For Less Than$...

Other stocks mentioned: CRM, ETSY, GSHD, QDEL, STMP, UMC
Business Wire - 5 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced it has entered a second phase of its collaboration to enhance & expand HTPK Simulation technology in ADMET Predictor.

Business Wire - 5 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has partnered with a large pharmaceutical company to validate the AIDD Module in ADMET Predictor 10.0 (APX).

Business Wire - 5 months ago

LANCASTER, Calif--(BUSINESS WIRE)--Simulations Plus today announced the release of ADMET Predictor 10.0 (APX) - a major upgrade with new AI-Driven Drug Design & Transporters Modules.

The Motley Fool - 5 months ago

Three great performing yet relatively unknown med-tech stocks with a high upside.

Other stocks mentioned: SDGR, VEEV
Business Wire - 6 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that chief executive officer Shawn O'Connor will present at LD Micro's LD 500 Virtual Conference on Sept.

Business Wire - 6 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the closing of its public offering and the full exercise of the underwriters’ option to purchase additional shares.

Business Wire - 6 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the entry into an underwriting agreement for the sale of 1,818,182 shares of its common stock priced at $55 per share

Business Wire - 7 months ago

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering.

Seeking Alpha - 7 months ago

Simulation Plus: One-Of-A-Kind Bioinformatics Co. With A 20% 3-Year CAGR

Zacks Investment Research - 7 months ago

Simulations Plus (SLP) third-quarter fiscal 2020 results reflect solid software and service revenue growth amid coronavirus crisis.

Seeking Alpha - 7 months ago

Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 9 months ago

Shares of these businesses are making big moves in response to upcoming index changes. Here are the must-know details.

Other stocks mentioned: DHC, HPP
The Motley Fool - 10 months ago

The Oracle of Omaha can't touch these high-growth businesses, but you can.

Other stocks mentioned: HQY, QTWO
Seeking Alpha - 10 months ago

Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q2 2020 Results - Earnings Call Transcript

About SLP

Simulations Plus develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus... [Read more...]

Industry
Health Information Services
IPO Date
Jun 18, 1997
Stock Exchange
NASDAQ
Ticker Symbol
SLP
Full Company Profile

Financial Performance

In 2020, SLP's revenue was $41.59 million, an increase of 22.43% compared to the previous year's $33.97 million. Earnings were $9.33 million, an increase of 8.72%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for SLP stock is "Buy." The 12-month stock price forecast is 87.00, which is an increase of 30.91% from the latest price.

Price Target
$87.00
(30.91% upside)
Analyst Consensus: Buy